Status of the ZUMA-3 trial of CAR T-cell product KTE-C19 for R/R ALL

CAR T-cells for acute lymphoblastic leukemia (ALL) treatment are promising, with a number of different agents in development. Here, Bijal Shah, MD, of the H. Lee Moffitt Cancer Center & Research I... Author: VJHemOnc Added: 03/09/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts